Skip to main content
Clinical Trials/JPRN-UMIN000012362
JPRN-UMIN000012362
Completed
未知

A prospective study of the efficacy and safety of Denosumab for the prevention of osteoporosis in malignant lymphoma patients treated with prednisolone-containing chemotherapy - A prospective study of the efficacy and safety of Denosumab for the prevention of osteoporosis in malignant lymphoma patients treated with prednisolone-containing chemotherapy (SMUIM4-NHL01)

Department of Medical Oncology and Hematology, Sapporo Medical University, School of Medicine0 sites30 target enrollmentNovember 21, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Malignant Lymphoma
Sponsor
Department of Medical Oncology and Hematology, Sapporo Medical University, School of Medicine
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 21, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Medical Oncology and Hematology, Sapporo Medical University, School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Uncontrolled hepatic disease, renal disease, heart disease, lung disease, diabetes mellitus, hypertention and infectious disease Active concomitant malignancy Severe psychiatric disorders Women who are pregnant or in lactation Hypersensitivity to the denosumab Dental therapy during this trial Current hypocalcemia Patient judged inappropriate for this study by the physicians

Outcomes

Primary Outcomes

Not specified

Similar Trials